Subrata Ghosh

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi request reprint Intestinal entry of prions
    S Ghosh
    Gastrointestinal Unit, Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK
    Z Gastroenterol 40:37-9. 2002
  2. pmc Alpha 4 integrin blockade in inflammatory bowel disease
    S Ghosh
    Imperial College London, Hammersmith Hospital, DuCane Road, London W12 0NN, UK
    Ann Rheum Dis 62:ii70-2. 2003
  3. ncbi request reprint Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab
    Subrata Ghosh
    Imperial College London, Hammersmith Hospital, DuCane Road, London W12 0NN, UK
    Expert Opin Biol Ther 3:995-1000. 2003
  4. ncbi request reprint Natalizumab for active Crohn's disease
    Subrata Ghosh
    Western General Hospital, Edinburgh, United Kingdom
    N Engl J Med 348:24-32. 2003
  5. ncbi request reprint Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
    David A van Heel
    Intestinal Inflammation and Repair Group, Department of Gastroenterology, Imperial College London, UK
    Lancet 365:1794-6. 2005
  6. doi request reprint Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland
    Evangelos A Russo
    Hammersmith Hospital, London, UK
    Eur J Gastroenterol Hepatol 22:334-9. 2010
  7. doi request reprint Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain
    Ayesha Akbar
    Department of Gastroenterology, Imperial College London, UK
    Gut 59:767-74. 2010
  8. pmc Learning the lessons of antitumour necrosis factor therapy-associated psoriasis
    Matt Shale
    Imperial College London, Hammersmith Hospital, London, United Kingdom
    Can J Gastroenterol 23:674-6. 2009
  9. ncbi request reprint NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease
    Matt Butler
    Department of Gastroenterology, Imperial College London, Faculty of Medicine, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK
    J Crohns Colitis 1:106-15. 2007
  10. doi request reprint Characterization of inflammatory bowel disease with urinary metabolic profiling
    Horace R T Williams
    Department of Gastroenterology and Hepatology, Imperial College London, London, UK
    Am J Gastroenterol 104:1435-44. 2009

Collaborators

Detail Information

Publications32

  1. ncbi request reprint Intestinal entry of prions
    S Ghosh
    Gastrointestinal Unit, Department of Medical Sciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, UK
    Z Gastroenterol 40:37-9. 2002
    ..The cellular prion protein expressed on the enteric nervous system might serve as the target for conversion to infectious prion protein and a route for spread to the central nervous system...
  2. pmc Alpha 4 integrin blockade in inflammatory bowel disease
    S Ghosh
    Imperial College London, Hammersmith Hospital, DuCane Road, London W12 0NN, UK
    Ann Rheum Dis 62:ii70-2. 2003
  3. ncbi request reprint Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab
    Subrata Ghosh
    Imperial College London, Hammersmith Hospital, DuCane Road, London W12 0NN, UK
    Expert Opin Biol Ther 3:995-1000. 2003
    ..Natalizumab was well-tolerated in this study. The Phase III trial results are awaited...
  4. ncbi request reprint Natalizumab for active Crohn's disease
    Subrata Ghosh
    Western General Hospital, Edinburgh, United Kingdom
    N Engl J Med 348:24-32. 2003
    ..In chronic inflammatory conditions such as Crohn's disease, the migration of leukocytes from the circulation into the parenchyma and their activation within inflammatory sites are mediated in part by alpha4 integrins...
  5. ncbi request reprint Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
    David A van Heel
    Intestinal Inflammation and Repair Group, Department of Gastroenterology, Imperial College London, UK
    Lancet 365:1794-6. 2005
    ....
  6. doi request reprint Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland
    Evangelos A Russo
    Hammersmith Hospital, London, UK
    Eur J Gastroenterol Hepatol 22:334-9. 2010
    ..Adalimumab is effective in inducing and maintaining response/remission in patients with Crohn's disease either naive to biological therapies or after secondary failure of infliximab...
  7. doi request reprint Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain
    Ayesha Akbar
    Department of Gastroenterology, Imperial College London, UK
    Gut 59:767-74. 2010
    ..We investigated TRPV1-immunoreactive fibres in rectosigmoid biopsies taken from such patients with correlation to abdominal pain severity...
  8. pmc Learning the lessons of antitumour necrosis factor therapy-associated psoriasis
    Matt Shale
    Imperial College London, Hammersmith Hospital, London, United Kingdom
    Can J Gastroenterol 23:674-6. 2009
    ..Therefore, withdrawal of therapy is generally not required for this adverse effect but referral to a dermatologist may be desirable for confirmation of diagnosis and treatment...
  9. ncbi request reprint NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease
    Matt Butler
    Department of Gastroenterology, Imperial College London, Faculty of Medicine, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK
    J Crohns Colitis 1:106-15. 2007
    ..As a consequence, Crohn's disease patients with defective NOD2 may be predisposed to the generation of strongly polarised Th1 responses against common commensal microorganisms...
  10. doi request reprint Characterization of inflammatory bowel disease with urinary metabolic profiling
    Horace R T Williams
    Department of Gastroenterology and Hepatology, Imperial College London, London, UK
    Am J Gastroenterol 104:1435-44. 2009
    ..This study tested the hypothesis that such metabolites differ between IBD and control cohorts, and that using multivariate pattern-recognition analysis, the cohorts could be distinguished by urine NMR spectroscopy...
  11. ncbi request reprint Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin
    Francesco Lanzarotto
    Imperial College London, Hammersmith Hospital, London, UK
    Drugs 66:1179-89. 2006
    ..Initial safety evaluation suggests that PML is very rare, despite its occurrence in one patient with CD receiving open-label natalizumab treatment...
  12. ncbi request reprint Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease
    Doris Meister
    Gastrointestinal Unit, University of Edinburgh, Western General Hospital, United Kingdom
    World J Gastroenterol 11:7466-72. 2005
    ..To investigate the influence of fish oil enriched enteral diet on intestinal tissues taken from Crohn's disease (CD), ulcerative colitis (UC) and non-inflamed non-IBD control patients in vitro...
  13. ncbi request reprint Infliximab in refractory coeliac disease
    Rakesh Chaudhary
    Gastroenterology Section, Imperial College London, Hammersmith Hospital, UK
    Eur J Gastroenterol Hepatol 17:603-4. 2005
    ..Refractory coeliac disease poses a therapeutic challenge to clinicians and carefully selected patients may benefit from anti-TNF therapy...
  14. ncbi request reprint Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders
    Anna Dahele
    Department of Medical Sciences, University of Edinburgh, Western General Hospital, Scotland
    Dig Dis Sci 47:2325-35. 2002
    ..In conclusion, whole gut lavage IgA anti-tissue transglutaminase antibody concentrations are higher in untreated celiac disease than in other gastrointestinal diseases...
  15. ncbi request reprint Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease
    Subrata Ghosh
    Department of Gastroenterology, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK
    Adv Drug Deliv Rev 56:915-20. 2004
    ..The relative importance of the several potential portals of intestinal entry of infectious prion proteins is uncertain but may determine susceptibility of the population and also potential preventive strategies...
  16. ncbi request reprint A common CTLA4 haplotype associated with coeliac disease
    Karen A Hunt
    Department of Gastroenterology, Imperial College London, Du Cane Road, London W12 0NN, UK
    Eur J Hum Genet 13:440-4. 2005
    ..Loss of tolerance to dietary antigens in coeliac disease may be mediated in part by heritable variants in co-signalling genes regulating T-cell responses...
  17. doi request reprint Beyond TNF, Th1 and Th2 in inflammatory bowel disease
    Matthew Shale
    Gastrointestinal Section, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
    Gut 57:1349-51. 2008
  18. pmc An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea
    W Gordon Brydon
    Department of Clinical Biochemistry, Western General Hospital, Edinburgh, UK
    Can J Gastroenterol 25:319-23. 2011
    ..The radionuclide selenium-labelled homocholic acid-taurine whole body retention test is expensive, labour intensive and of limited availability...
  19. ncbi request reprint Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence
    Emma L Armitage
    Gastrointestinal Unit, University of Edinburgh Department of Medical Sciences, Western General Hospital, Scotland, United Kingdom
    Gastroenterology 127:1051-7. 2004
    ..Many studies have investigated genetic influence or possible links with childhood events. We aimed to study sociodemographic and/or geographic distribution of juvenile=onset Crohn's disease in Scotland...
  20. ncbi request reprint Growth factors and trefoil peptides in gastrointestinal health and disease
    Raymond J Playford
    Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK
    Curr Opin Pharmacol 4:567-71. 2004
    ....
  21. ncbi request reprint Successful infliximab treatment for steroid-refractory celiac disease: a case report
    Helen R Gillett
    Gastrointestinal Unit, University Department of Medical Sciences, Western General Hospital, Edinburgh, Scotland
    Gastroenterology 122:800-5. 2002
    ..It is concluded that infliximab is an effective treatment that may be considered in a small number of patients with refractory celiac disease, resistant to other therapy...
  22. ncbi request reprint Endoscopic and histologic features of sodium phosphate bowel preparation-induced colonic ulceration: case report and review
    David A Watts
    Gastrointestinal Unit and Department of Pathology, Western General Hospital, Edinburgh, Scotland, UK
    Gastrointest Endosc 55:584-7. 2002
  23. ncbi request reprint Bioactive natural compounds for the treatment of gastrointestinal disorders
    Subrata Ghosh
    Department of Gastroenterology, Imperial College Faculty of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, U K
    Clin Sci (Lond) 104:547-56. 2003
    ....
  24. pmc The classics in perspective
    Julian Panes
    Department of Gastroenterology, Hospital Clinic Barcelona, CIBER EHD, Barcelona, Spain
    Gut 56:1184-6. 2007
  25. ncbi request reprint Infliximab use in Crohn's disease: impact on health care resources in the UK
    Derek P Jewell
    Gastroenterology Unit, University of Oxford, Sheffield, UK
    Eur J Gastroenterol Hepatol 17:1047-52. 2005
    ..To quantify the impact of infliximab therapy on health care resource utilization in the UK...
  26. ncbi request reprint Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure
    Danay Cibrian
    Center for Genetic Engineering and Biotechnology, Ave 31 e 158 and 190 Playa 10600, Havana, Cuba
    Clin Sci (Lond) 110:563-73. 2006
    ..In view of these findings, further studies appear justified...
  27. ncbi request reprint Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease
    David A van Heel
    Institute of Cell and Molecular Science, Barts and The London, Queen Mary s School of Medicine and Dentistry, London, UK
    Inflamm Bowel Dis 12:598-605. 2006
    ..Rare NOD2 variants occur, but it is difficult to both identify them and assess their functional effect. We assessed the true frequency of defective muramyl dipeptide sensing in Crohn's disease and developed a rapid diagnostic assay...
  28. pmc Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents
    Tania Marchbank
    Centre for Gastroenterology, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary University of London, London, UK
    Am J Pathol 171:1462-73. 2007
    ..We conclude that administration of PSTI may provide a novel method of stabilizing intestinal mucosa against noxious agents and stimulating repair after injury...
  29. ncbi request reprint Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium
    Matt Butler
    Department of Gastroenterology, Imperial College London Faculty of Medicine, London, UK
    Eur J Immunol 36:864-74. 2006
    ..Thus, polarised epithelial cell monolayers create a 'tolerogenic' environment which modulates the activity of DC. These results highlight the regulatory importance of the epithelial microenvironment at mucosal surfaces...
  30. ncbi request reprint Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair
    Raymond J Playford
    Centre for Gastroenterology, Barts and The London, Queen Mary s School of Medicine and Dentistry, London, United Kingdom
    Gastroenterology 131:809-17. 2006
    ..Their potential role in maintaining gastrointestinal mucosal integrity and repair is, however, unclear...
  31. ncbi request reprint Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease
    David A van Heel
    Gastroenterology Section, Imperial College London Hammersmith Campus, UK
    Eur J Immunol 36:1629-35. 2006
    ..Responses to specific NOD1 agonists are unaffected by NOD2 genotype, suggesting independent action of the NOD1 and NOD2 pathways...
  32. ncbi request reprint Operational feasibility of implementing community-based zinc supplementation: impact on childhood diarrheal morbidity
    Dhirendra N Gupta
    National Institute of Cholera and Enteric Diseases, Beliaghata, Kolkata 700010, India
    Pediatr Infect Dis J 26:306-10. 2007
    ..To determine the effect of zinc supplementation on diarrheal incidence and to discover any operational constraints of zinc supplementation at the community level...